The mission of Neurogene is to treat devastating neurological diseases to improve the lives of patients and families impacted by these rare diseases.
Neurogene is a clinical-stage biotechnology company focused on developing life-changing genetic medicines for people and their families impacted by devastating neurological diseases. The Company is using a biology-first approach paired with optimized delivery to develop purpose-built genetic medicines, including programs powered by its novel and proprietary EXACT™ transgene regulation technology. Neurogene is advancing its lead gene therapy program, NGN-401, as a potential best-in-class, one-time treatment for Rett syndrome.
Change
Volume
52 Week High
52 Week Low
Minimum 15 minutes delayed. Source: LSEG